Table IV.
Maximum tensile strength (N) | Tendon gliding distance (mm) | ||||
---|---|---|---|---|---|
Group | Sample | 4th week | 8th week | 4th week | 8th week |
Normal | 10 | 84.48±4.34 | 88.47±5.41 | 3.30±0.34 | 3.26±0.45 |
Model | 10 | 61.55±3.41a | 70.67±4.67a | 1.90±0.27a | 1.86±0.22a |
Negative control-siRNA | 10 | 59.45±3.56a | 69.58±4.42a | 1.94±0.17a | 1.82±0.32a |
Combine | 10 | 60.54±4.21a | 69.77±3.56a | 1.91±0.57a | 1.80±0.38a |
Thermal pretreatment | 10 | 79.05±4.68a,b | 87.34±4.53b | 2.51±0.41a,b | 3.21±0.24b |
Heat shock protein 70-siRNA | 10 | 45.78±4.32a,b | 51.67±3.78a,b | 1.34±0.56a,b | 1.21±0.58a,b |
There were 10 rats in each group, with 5 rats observed 4 weeks following the surgery and 5 rats observed 8 weeks following the surgery. The data were analyzed using repeat measures analysis of variance.
P<0.05 vs. the normal group
P<0.05 vs. the model group. siRNA, small interfering RNA.